UCB-guided surrogate Bayesian optimization (validated for drug discovery) will reduce coalition-based deviations in decentralized green hydrogen markets by dynamically reweighting exploration-exploitation trade-offs in multi-agent reinforcement learning controllers for grid-integrated electrolyzers.

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Spine & Adversarial ReadReady for validation

“This hypothesis tests whether augmenting multi-agent reinforcement learning electrolyzer controllers with UCB-guided Bayesian-optimization surrogates measurably reduces coalition-based deviation events in decentralized green hydrogen markets compared to non-Bayesian MARL baselines.”

• highThe hypothesis imports 'validated for drug discovery' as a credibility anchor for UCB-guided Bayesian optimization, but drug-discovery BO operates on smooth, low-dimensional, stationary black-box functions (e.g., molecular property landscapes), whereas multi-agent hydrogen markets are non-stationary, adversarial, and high-dimensional due to concurrent agent learning — the transfer of validity across these domains is asserted, not established.
  The protocol includes explicit non-stationarity stress-testing (concurrent learning dynamics, sensitivity analysis across agent counts) and an ablation isolating the surrogate-modeling contribution, but does not yet include a theoretical proof that GP-UCB regret bounds hold under non-stationary multi-agent settings — this remains a genuine open gap requiring either theoretical analysis or explicit acknowledgment that empirical results only demonstrate practical, not guaranteed, transfer.
• mediumWhy choose GP-based UCB and Shapley-value-based coalition deviation metrics specifically, rather than alternative exploration strategies (Thompson sampling, information-directed sampling) or alternative stability metrics (core stability, epsilon-Nash deviation)? The methodology does not justify these specific choices over equally plausible alternatives, which is a common source of rejection.
  GP-UCB is chosen for its theoretical regret bounds and direct lineage to the drug-discovery precedent cited in the hypothesis, and Shapley value is chosen because it is the standard fair-allocation benchmark in cooperative game theory allowing operational deviation detection; however, the EVP does not include a comparison arm against Thompson sampling or core-stability metrics, so the specific-method advantage remains unestablished — a recommended addition is a 4th arm (Thompson sampling) in the full validation to test whether the effect is UCB-specific or generic-to-Bayesian-exploration.
• highThe 500-episode, multi-seed simulation is entirely synthetic; no real electrolyzer or real market pilot is proposed, so even a fully positive result only demonstrates simulator-internal consistency, not real-world market stabilization — a skeptic will ask whether this is falsifiable in any way that matters for the stated impact (grid operators, energy traders).
  This is only a minimum-viable/simulation-stage EVP; the protocol explicitly frames simulation as a necessary-but-insufficient first gate, with real-world validation (hardware-in-loop electrolyzer testbed, small-scale pilot market) deferred to a follow-on phase not costed here — this is an acknowledged scope limitation rather than a resolved gap.

Experimental Protocol

ROI Projection

Implementation Sketch

# Environment
class H2MarketEnv(PettingZoo.ParallelEnv):
    agents = [ElectrolyzerAgent(i) for i in range(N)]
    state = {price_signal, renewable_forecast, grid_constraint}
    def step(actions): 
        clear_market(bids=actions)
        compute_payoffs(); compute_shapley_baseline()
        return obs, rewards, coalition_deviation_flag

# UCB-BO Controller (per agent)
class UCBBOController:
    surrogate = GaussianProcessRegressor(kernel=Matern)
    def select_action(obs):
        candidates = discretize_action_space()
        mu, sigma = surrogate.predict(candidates)
        ucb = mu + beta * sigma
        action = argmax(ucb)
        return action
    def update(obs, action, reward):
        surrogate.fit_incremental(obs, action, reward)

# Baseline: QMIX/MADDPG epsilon-greedy (RLlib default)

# Training loop
for episode in range(500 * 30 seeds * 3 regimes * 2 pop_sizes):
    run_episode(env, controllers)
    log_metrics(coalition_deviation, regret, convergence)

# Analysis
bootstrap_test(ucb_bo_results, baseline_results, n_resamples=10000)
ablation: set beta=0 -> isolate surrogate vs exploration-bonus effect